Author: Dr. Pawan Gupta

Dr. Pawan Gupta is a trusted Senior Surgical Oncologist, social activist, and author, engaged in creating awareness and changing the way cancer is perceived in society. He is a renowned transformational speaker on cancer chronic diseases and lifestyle specifically tobacco. Thousands have benefitted from his workshops, seminars, camps, and training programs. He has been featured in Buzz Creator and on many channels on TV. He is the Founder of ICanCaRe, an Innovative enterprise for Cancer Care and Rehabilitation. Working extensively in Tobacco Cessation data-driven protocol-based intervention through a network of Specialists and experts on ICanCaRe APP, Virtual Clinics, and ICanCaRe National Quitline. National Convenor for Tobacco Cessation courses for the first time in India introduced under Gujarat University His populist campaigns “WIN OVER CANCER”, “SAVE the Youth – Win over tobacco”, “Chota Daana”, “Catch them Early”, and “My Hygiene My Responsibility” has gained him wide accolades. In his mission to win over cancer, he has a unique methodological approach to quitting tobacco. The book WIN OVER TOBACCO – MADE EASY is a step-by-step guide for tobacco addicts to overcome their cravings. The Book had more than 10000 Downloads within 30 Days of being made available. He received the prestigious ICD International Award in 2007, Vivekananda Sister Margarette Award 2017 and Delhi NGO leadership Award 2017, AIECS award 2018, Asia Africa Leadership in Social Innovation 2019, MICC Innovation Award 2019, Rashtriya Prabasi Odia Paribar Award 2019. Professionally he has conducted more than 11000 cancer surgeries and was a pioneer in establishing and modernizing surgical oncology in some of the major hospitals in Delhi NCR. He did his graduation and post-graduation from SCB Medical College, Cuttack. He enhanced his surgical skills M.Ch and Fellowship in Surgical Oncology from Gujarat Cancer Research Institute (GCRI), Ahmedabad. He has held several positions during his career in various hospitals. Dr. Pawan has published 30 papers in National and International journals and is actively involved in several research projects. He is an active member of the Telemedicine Society of India, India Association of Surgical Oncology, Association of Surgeons of India, and Foundation for Head and Neck Oncology. He is seen as a mentor of strayed souls, and a soothing balm to those tormented by cancer.

“Smokers with diabetes and hypertension at higher risk of Cardiovascular events”. – ICanCaRe

“Smokers with diabetes and hypertension at higher risk of Cardiovascular events”. – ICanCaRe

Introduction:

I continuation of our previous blog article on the risk of smoking and diabetes type 2, a recent article on a link of CVD with diabetes, highlights the need for a comprehensive smoking cessation program for such patients.

In the complex landscape of managing type 2 diabetes, the link between blood pressure levels and cardiovascular disease (CVD) mortality has emerged as a critical focal point. A recent study published in the Journal of the American Heart Association delves into the intricate relationship between systolic and diastolic blood pressure (BP) levels and their impact on mortality in patients with type 2 diabetes. The findings, drawn from a multi-institutional diabetes registry in Singapore, underscore the urgency for comprehensive interventions like ICanCaRe to address the cardiovascular risks associated with type 2 diabetes.

Unraveling the Study’s Objectives:

Led by Loraine Liping Seng and her colleagues, the study aimed to unravel the correlation between systolic and diastolic BP levels and the risk of CVD mortality in patients with type 2 diabetes. Additionally, the study explored associations with all-cause mortality, the composite outcome of all-cause mortality and CVD hospitalization, and the composite outcome of CVD mortality and hospitalization due to specific cardiovascular events such as myocardial infarction (MI), heart failure (HF), stroke, bypass surgery (CABG), and percutaneous coronary intervention (PCI).

The Singaporean Perspective:

Utilizing data from a multi-ethnic Asian patient pool – Chinese, Malay, and Indian – the study delved into a rich repository of information encompassing primary care to hospital-based care. The comprehensive analysis included 83,721 patients with type 2 diabetes over a span of seven years. Notably, almost 80% of the participants were on antihypertensive treatment, highlighting the prevalence of the condition in this population.

Key Findings and Implications:

The study’s primary outcome revealed a notable association between clinic systolic BP of 130 mm Hg or higher and/or diastolic BP of 90 mm Hg or greater with an increased risk of CVD mortality in patients with type 2 diabetes. Intriguingly, adverse cardiovascular outcomes were also paradoxically linked to diastolic blood pressure levels below 70 mm Hg. While the authors acknowledge the potential influence of reverse causality, the study emphasizes the importance of maintaining systolic BP below 130 mm Hg and diastolic BP below 90 mm Hg in individuals with type 2 diabetes.

ICanCaRe: A Holistic Approach to Cardiovascular and diabetic Health:

In light of these findings, the ICanCaRe Tobacco Intervention program takes center stage as a holistic approach to address the multifaceted challenges posed by type 2 diabetes. Recognizing the intricate interplay between cardiovascular health, diabetes, and other lifestyle factors, ICanCaRe empowers individuals to make informed choices and adopt a comprehensive approach to well-being. The ICanCaRe program is designed to offer personalized support to individuals seeking to quit Tobacco. Understanding that each journey is unique, the program tailors its strategies to meet each participant’s specific needs and challenges. (www.app.icancare.in). Medical assistance in a protocol-based approach is provided by Certified Tobacco Cessation Specialists. This multi-faceted ABCD approach for tobacco cessation ensures that individuals have access to all necessary resources to 100% quit smoking or Chewing tobacco.

Conclusion:

As the nexus between type 2 diabetes, blood pressure levels, and cardiovascular risks becomes clearer, interventions like ICanCaRe gain significance in the realm of patient care. By integrating the latest research findings into its framework, ICanCaRe supports tobacco cessation, guiding individuals through the complexities of managing diabetes and promoting cardiovascular health. In a world where data illuminates the path to better outcomes, the ICanCaRe program becomes an invaluable tool in the fight against the complications of type 2 diabetes with increased risk with smoking, offering a lifeline to those seeking a healthier, more empowered future.

Reference:

  1. Loraine Liping Seng, et al. Real-world systolic and diastolic blood pressure levels and cardiovascular mortality in patients with type 2 diabetes-results from a large registry cohort in Asia. J Am Heart Assoc. 2023 Nov 28:e030772. doi: 10.1161/JAHA.123.030772.
  2. World Health Organization, International Diabetes Federation, and the University of Newcastle. “Policy Brief on Smoking and Type 2 Diabetes.” This brief offers a comprehensive overview of the research linking smoking cessation to a reduced risk of type 2 diabetes.
  3. ICanCaRe. “Tobacco Cessation Program Overview.” www.icancare.in
  4. American Diabetes Association. “The Impact of Smoking on Diabetes and Diabetes Management.” This article discusses the implications of smoking on diabetes management and the benefits of cessation.
  5. National Institute of Diabetes and Digestive and Kidney Diseases. “Smoking and Diabetes.” This resource offers a deeper understanding of how smoking affects diabetes risk and control.
  6. ICanCaRe. (2021). ABCD of Tobacco Cessation. https://www.icancare.org/abcd.html

#icancare #diabetesandSmoking #smoking #quittobacco #icancareapp #CVDandsmoking

PRISm – A COPD Risk factor and Smoking Cessation advocated by ICanCaRe

Introduction:

Preserved Ratio Impaired Spirometry (PRISm) is a critical indicator characterized by an FEV1 of <80% predicted and a FEV1/FVC ratio of >0.70. Identified as a precursor to Chronic Obstructive Pulmonary Disease (COPD), PRISm demands careful monitoring, particularly in individuals with respiratory symptoms. The studies by Mariko Kogo et al. and Daniel H Higbee et al. shed light on the significant correlation between PRISm, respiratory symptoms, and the heightened risk of developing COPD, emphasizing the urgency for effective tobacco cessation interventions. In this context, the ICanCaRe tobacco cessation intervention program emerges as a beacon of hope, advocating for smoking cessation on an individual basis. (www.icancare.in). This blog is in series with the previous blog on Increased risk of Asthma in Children exposed to secondhand smoke.( ICanCaRe Blog) (ICanCaRe LinkedIn)

Understanding the PRISm Challenge:

PRISm, when associated with respiratory symptoms such as cough, sputum, and dyspnea, poses an independent risk factor for COPD development, especially in individuals with a history of smoking. Even without symptoms at baseline, PRISm can progress within five years, leading to airflow limitations. In addition, individuals with PRISm could exhibit increased respiratory symptoms, poor health-related quality of life, multiple comorbidities, and increased mortality compared with those with normal spirometry. The quantitative assessment capability of PRISm becomes a crucial tool for identifying and addressing the risks faced by smokers, reinforcing the need for smoking cessation.

The ICanCaRe Tobacco Cessation Intervention program quantifies the need for individuals and the digital protocol puts the urgency for smoking cessation on an individual basis.

ICanCaRe: A Holistic Approach to Tobacco Cessation:

ICanCaRe tobacco cessation wellness program stands out as a comprehensive, evidence-based tobacco cessation program aligned with the latest research findings. Grounded in the insights from studies by Kogo et al. and Higbee et al., ICanCaRe adopts a holistic approach to empower individuals to overcome addiction, ensuring long-term abstinence, and reducing the risk of respiratory complications.

Key Components of ICanCaRe – ABCD of Tobacco Cessation:

1. ACTIVE MOTIVATION: ICanCaRe actively motivates tobacco users through quantitative and qualitative assessments, estimating the progressive risk associated with continued smoking.

2. BEHAVIOR INTERVENTION: Tailored behavioral counseling strategies address unique triggers contributing to tobacco addiction, crucial for addressing psychological aspects and enhancing successful cessation.

3. COMORBIDITY MANAGEMENT: Clinical assessments for associated morbidities are conducted, with specialists providing personalized care.

4. DRUGS and MEDICATIONS – Pharmacotherapy: The program integrates evidence-based pharmacotherapies to manage withdrawal symptoms and cravings, enhancing the effectiveness of the intervention and ensuring complete cessation.

Call 011-43077695 or write to info@icancare.in and download the ICanCaRe tobacco Wellness APP (http://app.icancare.in)

Conclusion – Empowering Individuals for a Tobacco-Free Future:

As we confront the challenges posed by PRISm and its link to respiratory symptoms, the ICanCaRe Tobacco Cessation Intervention program stands as a beacon of hope. By integrating the latest research findings into its framework, ICanCaRe not only recognizes the severity of the issue but actively addresses it through a personalized and holistic approach. It serves as a call to action for individuals to take charge of their respiratory health, break free from tobacco addiction, and embrace a future free from the shackles of compromised lung function.

ICanCaRe stands at the forefront of the battle against tobacco addiction, offering a lifeline to those grappling with the consequences of PRISm. Through its holistic approach, the program not only supports individuals in their journey to quit smoking but also contributes to a healthier, tobacco-free future for communities worldwide.

It is time we #savetheyouth. SAVE our next generation!! #knowtobacco to #notobacco

Reference:

1. Mariko Kogo et al. Longitudinal changes and association of respiratory symptoms with preserved ratio impaired spirometry (PRISm): The Nagahama Study. Ann Am Thorac Soc. 2023 Nov;20(11):1578-1586. doi: 10.1513/AnnalsATS.202301-050OC.

2. Daniel H Higbee et al. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med. 2022 Feb;10(2):149-157. doi: 10.1016/S2213-2600(21)00369-6.

Author –

1. Dr Shikha Jindal Consultant Pulmonologist Dr Shikha Jindal Gupta MD, CTCS(GU)

– Sr Consultant Pulmonologist,

– Certified Tobacco Cessation Specialist (Gujarat University by ICanCaRe)

Neo Super-Speciality Hospital, Noida

2. Dr Pawan Gupta M.Ch. Cancer Surgeon

 –  Sr. Director, Surgical Oncology

MAX Institute of Cancer Care, Vaishali, Patparganj and Noida

–          Founder Director – ICanCaRe – Innovative Cancer Care and Rehabilitation ICanCaRe, ICanCaRe Academy

–          Master Trainer – Tobacco Cessation Courses, Oral Cancers

#icancare #asthmaawareness #secondhandsmoke #icancareapp #pawangupta #icancareacademy #knowtobacco #Prism #COPD #smoking #quitsmoking

Suneela Garg Dr. Paramita Sengupta Rakesh Gupta Dr Pawan Gupta Dr REENA R KUMAR Shruti Agrawal Rishabh Agrawal Dr. Siddhi Hathiwala Dr Neha Agrawal ICanCaRe – Innovative Cancer Care and Rehabilitation Dr Shikha Jindal Consultant Pulmonologist

Unlock Wellness: Solutions to Your Health Challenges

Online Wellness Seminar Hosted by Max Institute of Cancer Care, Vaishali and Rotary Clubs

**Event Title**: Unlock Wellness: Solutions to Your Health Challenges

**Date**: November 25, 2023

Organizers:

– Rotary Club of Delhi Preet Vihar (President Rtn. Emili Munshi, Contact: 9873335016)

– Rotaract Club of SBSEC (President Rtr. Aman Rawat, Contact: 9718227284)

**Chief Guest**: Dr. Pawan Gupta M.Ch., Senior Director and Cancer Surgeon, MAX Hospital, Vaishali

**Session Conductor**: Dr. Annu Kanojia

Overview:

On November 25, 2023, an enlightening online health session titled “Unlock Wellness: Solutions to Your Health Challenges” was conducted, garnering the participation of 62 individuals. The session, led by renowned cancer surgeon Dr. Pawan Gupta M.Ch. from MAX Hospital, Vaishali focused on strategies for maintaining health and preventing cancer.

Key Highlights:

1. **Promoting Healthy Eating Habits**:

   – Avoidance of tobacco and alcohol.

   – Adherence to a balanced diet rich in nutrients.

2. **Adopting a Healthy Lifestyle**:

   – Importance of meditation for mental health, specifically Sync Energy Pranayam.

   – Regular exercise for physical fitness and weight management.

3. **Regular Health Care and Monitoring**:

   – Emphasis on regular self and clinical check-ups.

   – Advocacy for immunization, such as HPV vaccines.

   – Safe exposure to sunlight for Vitamin D, while being cautious of skin cancer risks.

The discussion revealed that tobacco use is a major cause of cancer, leading to a collective desire among participants to combat tobacco addiction and become “Tobacco Marshals” to influence societal change.

Dr. Gupta emphasized the feasibility of quitting tobacco with proper support, highlighting MAX Vaishali’s pioneering tobacco wellness program. He also demonstrated practical self-examination techniques for early cancer detection, including the 4-finger test and Chota Daana examination for oral cavity assessment, and introduced the TRISCaRe mouth opener device.

Mrs. Sonal Bhatia, National Leader Tobacco MARSHAL and PDC Inner Wheel 310 emphasized her mission to “SAVE the youth – NO ONE SHOULD DIE BECAUSE OF TOBACCO”

The session concluded with President Emili Munshi summarizing the action points and emphasizing the need for continued efforts to safeguard youth health.

**Hashtags**: #MAX #SaveTheYouth #TobaccoMarshal #ICanCare #PawanGupta #Rotary #RotaryClubOfDelhiPreetVihar #EmiliMunshi #AmanRawat #RotaractClubSBSEC